profit from every $100 of sales.
$0$100
Prenetics Global
$0.01-12.76% today
-74.7% in 1 year
1-year low $0.011-year high $0.04
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Prenetics Global sold, what it kept, and what it did with the cash.
Sales went from $13.2 million in 2022 to $92.4 million in 2025, with -$37.7 million of profit last year.
SalesProfit
Prenetics Global vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Prenetics Global | No profit yet | ||
 Illumina | 36.8× · Expensive | ||
 Labcorp Holdings | 34.3× · Expensive | ||
 Quest Diagnostics | 28.8× · Fair price | ||
 Guardant Health | No profit yet |
AI analysis
An AI analyst reads Prenetics Global's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 13 | 6 | 16 | 92 | |
| 4 | 1 | 9 | 49 | |
| -66 | -42 | -38 | -38 | |
| -218 | -35 | -40 | -32 | |
| -190 | -63 | -46 | -38 | |
| – | – | – | – | |
| 27.5% | 19.1% | 58.2% | 52.8% | |
| -500.7% | -690.0% | -240.2% | -41.3% | |
| -1,446.8% | -1,019.1% | -290.6% | -40.8% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 312 | 254 | 214 | 206 |
| Cash | 147 | 46 | 52 | 32 |
| Total debt | 7 | 2 | 6 | 2 |
| Total liabilities | 69 | 44 | 42 | 50 |
| 237 | 206 | 170 | 156 | |
| – | – | – | – | |
| -73.1% | -16.2% | -20.6% | -18.0% | |
| -80.3% | -30.4% | -27.2% | -24.1% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 15 | -14 | -29 | -22 | |
| 6 | 1 | 1 | 55 | |
| 8 | -15 | -30 | -76 | |
| Dividends paid | 0 | 0 | 0 | 0 |
| 1 | 1 | 1 | 0 | |
| 121 | 11 | 12 | 8 |
Valuation
- –
- –
- 0.49
- 1.6×
- 2.6×
- –
- –
- -8,851.8%
- -20.4%
- 0.0%
Profitability
- 52.8%
- -41.3%
- -40.8%
- -43.1%
- -22.1%
- -71.8%
- -36.0%
- -28.7%
- -22.3%
- 5.8%
Growth
- +91.5%
- –
- +26.5%
- –
- +39.6%
Financial health
- -0.9×
- 0.01
- 1.1%
- -167.7×
- 3.01
- 2.76
- 0.47
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 18%of 952
Bottom 7%of 884
Top 7%of 886
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 14, 2026 | -1.14 | -0.84 | −35.9% |
| Feb 18, 2026 | -1.77 | -0.33 | −436.4% |
| Nov 10, 2025 | -0.53 | -0.55 | +3.1% |
| Sep 12, 2025 | -0.94 | -0.71 | −31.9% |
| Aug 22, 2025 | -0.80 | – | – |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
36No pass
Benjamin Graham
58No pass
Philip Fisher
41No pass
Peter Lynch
71Pass
Joel Greenblatt
0No pass
Charlie Munger
29No pass
Terry Smith
28No pass
Questions about Prenetics Global
Is Prenetics Global a good stock to buy?
A business with weak numbers that is not profitable yet. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Prenetics Global AI analysis
What does Prenetics Global do?
Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. It is in Medical - Diagnostics & Research.
Does Prenetics Global pay a dividend?
No. Prenetics Global does not pay a dividend at the moment.
How has Prenetics Global stock done over the past year?
Down 74.7% over the past twelve months, to $0.01. It traded between $0.01 and $0.04 and is 78.6% below its high.
Who are Prenetics Global's competitors?
The largest listed companies in the same industry are Illumina, Labcorp Holdings, Quest Diagnostics and Guardant Health. The peers table on this page compares their profit, growth and price with Prenetics Global's.
Prices: daily closes to Nov 9, 2026. Fundamentals: company reports via invest-like data.